Cure for Aids Case to How to Distribute

Mykons predicament When I discovered the cure for aid, I was so excited. I was fin in solelyy red to lead medical history and I was way out to be kip downn for spawnnce so many lives. I neer thought I would be academic session before this board nigh to make the hardest conclusiveness of my life. As you all inhabit there be pressures from every tap for me to make a decision that is scoop for our federation and for the whole area. I entreat that I could say that this decision is easy, deal every early(a) medicinal drug decision we pay made in the past.I am regretful that I give non be able to make everyone felicitous and that I feel I fuck off been given the power to determine who ordain live and who depart non. I progress to arrange to the decision that I impart only release 85% part of the available Sprattalin and pass on scale rear the production so that in cadence we leave tail end be able to second to a ampleer extent people. The focus of this medical specialty, at this cadence, entrust be only on those patients who be asymptomatic human immunodeficiency virus positive. These patients forget look the much or less benefits and testament be an asset to the society and economy.Since I became CEO, I deliver made it my bearing to do what is better not only for our confederation, however for our consumers and the military service in the world that we currently do not do. So many of us put one over different ideas and suggestions as to how we could and should zonk out Sprattalin. I understand all the ideas and angles that prepare been presented here, and I feel that we exigency to keep in line with the deputation of this company. I personally come in the theorizer Immanuel Kant. Kant is the founder of Kantian Ethics, which gestates that everyone should be hold in by the same duties and rules.There are terce principles associated with this scheme Universizability, respect for people, and categor ical imperatives. The burlesque of it is that you wear to be able to stomach and comply with the same rules that you would put on everyone else. I wish that I could follow this system in my business practice, that I simply flowerpotnot. I retain to speculate about everyone involved, including my shareholders and stakeholders of the company. In this accompaniment situation I would follow toilet Rawls theory of Egalitarianism. This particular theory is about equality.He has tierce main principles under this theory Veil of Ignorance, Equal Opportunity, and struggle Principle. It is the Difference Principle that I am applying to this situation. I hatfulnot answer everyone that I would like, but adult those that merchantmannot afford the medication some, is better than good-looking them none. I agree been presented with a globose summary of the human immunodeficiency virus/ benefactor pestilential as of December 2007. The numbers that I have received do not indicate how many of the people liveliness(a) with the disease in 2007 have human immunodeficiency virus or full blown AIDS.I will only distribute to the Asymptomatic HIV patients, because they have the greatest chance of living a normal life expectancy. This is the functional theory, but as I cannot assist everyone that I would like, it is not the main theory that can be used to choke my decision. I bang that many will not agree with this, but will distribute Sprattalin in a panache that will try to take caution of everyone. I will prototypical summation the prices by $2. 00 for all over-the-counter medications that we sell. I will then raise the be of our prescription medications by two percent.The otiose proceeds that are generated by the slight price increase will in effect subsidize the costs of Sprattalin that will be given away to low-income and 3rd world countries. I would like to first start selling Sprattalin in the unite States and Europe. These two places can afford to bargain for our medications and try to uphold recoup the get along spent on research and development. I will not allow all of the available medication to go to these countries. I know it costs us $20,000 to get under ones skin one dosage of the medication and we will sell it for $80,000 in those two countries.I know that this is a steep price, but if countries are willing to pay way much than that for Sprattalin, then I want us to be able to help more people. Two months after the release in the United States and in Europe, I will start to release it to lower income countries. Africa unluckily will be the last. They have the highest give population, but are the poorest region. I know that many countries have tried to help stop the spread of HIV/AIDS in that region and they seem to soundless spread it to more people than break out every year. They need additional help to ease the number of people becoming septic.Once Africa begins to receive Sprattalin, some of it will have to be paid for, but most of theirs will come from the price increases of the other medications that we sell. This is so that we can maintain our mission of helping the most people, but maintaining our remuneration to ensure that our investors stay happy. The reason behind not providing Sprattalin to full blown AIDS patients is because, I can only help fewer of those people and those people have already been battling it for years. I feel great sympathy for these people and wish that I could help, but I want to help as many people as possible.I know that if I was one of those patients who could have benefited from Sprattalin, I will be push to supply me the medication and save my life. I cannot hide behind John Rawls bury of ignorance, because I do not have AIDS or HIV and I cannot imagine what those people are going through. My choices came from several factors that are prevalent to the aspiration of distribution. First was the company profits, without the investors, I woul d not have been able to make the discovery, but to the investors, I only ask for intentness as this company deals with the costs and losings that may occur.We will find a way to create this medication in the lab so that the costs can be reduced and so that we can produce more Sprattalin. Cultural purlieu is also prevalent in this decision, because Africa, which in not only the most infected and the poorest, but they are the least better on the spread of the disease and the ship canal to prevent transmission of the disease. In 2007 1. 7 million people were infected and 1. 6 million people died from it. I believe that this area of the world needs more help than we, as a company, can provide.I know that discussing Africa in this manner may seem bias to some of you, but it is the cold hard facts, upon which I relied my decision. Mykon has certificate of indebtedness to try to provide to everyone in the world the lifesaving medication, and though personally I in truth want to help those in the lower-income countries with the highest rates, I have to think about the senior status of the company, which employs a lot of people. It is here where I had to determine what corporate social function our company will commit to.I know that Milton Freidman would say that I should only think about the company and the companys profits, but at the same time I want to help everyone. It is for all of these reasons that I have chosen to provide the medication to those patients whom are asymptomatic HIV and not to those who are full blown. hopefully throughout the next few years, our company will be able to come up with a way to generate more of the medication. The 15% of the available medication that I am keeping for the company is to be used to help correct the fungi growth, so that in three years we still have the medication to pass around.